Mr. Burns has provided the leadership for Glaukos since its founding in 2001 to create the premier device franchise in glaucoma treatment– a business that was recently ranked #19 by the Wall Street Journal in a review of over 5000 venture-backed companies. He has built substantial value, delivered rapid growth and created entirely new commercial product classes and global markets in senior leadership roles at three major, successful start-up companies.
Prior to Glaukos, Mr. Burns led Eyetech (acquired by OSI Pharmaceuticals, Inc.) as President & COO, Director and raised $108M in a final private placement round to prepare the business for a successful $157M initial public offering. At Chiron Vision, Mr. Burns served as Sr. Vice President and GM, to build that business from a start-up in 1990 to a successful $310 million acquisition by Bausch & Lomb in 1998. Mr. Burns has served as an Entrepreneur-in-Residence at Versant Ventures, a distinguished health-care venture capital firm. As a leading serial entrepreneur, Mr. Burns has raised a quarter billion dollars to date in private placements to build successful businesses. Mr. Burns received his bachelor’s degree in history from Yale University.